Skip to main content
See every side of every news story
Published loading...Updated

The Best Stocks to Invest $1,000 in Right Now

Summary by The Motley Fool
Key PointsCRISPR Therapeutics is a potential home run if it can build on its Casgevy approval.One bad product has brought Zoetis to its knees -- but the selling is overdone.Danaher has slumped since the pandemic, but a recent acquisition could spark a rebound.10 stocks we like better than CRISPR Therapeutics › Long-term investing is about building your portfolio brick by brick. That could mean adding money weekly, monthly, or whenever you have e…

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Motley Fool broke the news in Alexandria, United States on Monday, June 22, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal